• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OPT

OPTHEA LIMITED - Announcements

0.00% ! 60.0¢
Market Cap $820.7M  !

Opthea Limited is an Australia-based clinical-stage biopharmaceutical company. The... Opthea Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is engaged in developing novel therapies to address the unmet need in the treatment of prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). Its lead product candidate, sozinibercept (OPT-302), is being evaluated in two pivotal Phase 3 clinical trials for use in combination with standard-of-care anti-VEGF-A monotherapies for the treatment of wet AMD and DME. The Company has also manufactured OPT-302 for use in Phase III clinical trials, conducts activities to support the commercialization of the product and expanded its management team in the United States to facilitate broader oversight and execution of its Phase III program. Its development activities are based on an intellectual property portfolio covering key targets (Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3).More

Announcements



Filters [Clear]
  • Price Sensitive: Yes
OPT S&P DJI Announces September 2025 Quarterly RebalancePRICE SENSITIVE05/09/25 download Created with Sketch. 121.47KB
OPT Preliminary Final ReportPRICE SENSITIVE29/08/25 download Created with Sketch. 325.85KB
OPT Corporate Update Investor CallPRICE SENSITIVE20/08/25 download Created with Sketch. 296.94KB
OPT Opthea Provides Corporate UpdatePRICE SENSITIVE19/08/25 download Created with Sketch. 196.61KB
OPT Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE30/07/25 download Created with Sketch. 1.48MB
OPT Long Term Suspended EntitiesPRICE SENSITIVE16/07/25 download Created with Sketch. 262.84KB
OPT Opthea Provides Corporate UpdatePRICE SENSITIVE02/06/25 download Created with Sketch. 487.15KB
OPT Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE30/04/25 download Created with Sketch. 1.48MB
OPT Opthea Provides Corporate UpdatePRICE SENSITIVE10/04/25 download Created with Sketch. 485.05KB
OPT Continuation of Suspension from QuotationPRICE SENSITIVE31/03/25 download Created with Sketch. 109.5KB
OPT Opthea Announces Decision to Discontinue Wet AMD TrialsPRICE SENSITIVE31/03/25 download Created with Sketch. 491.5KB
OPT Opthea Announces COAST Phase 3 Trial Topline ResultsPRICE SENSITIVE24/03/25 download Created with Sketch. 520.92KB
OPT Voluntary suspensionPRICE SENSITIVE19/03/25 download Created with Sketch. 1.07MB
OPT Trading HaltPRICE SENSITIVE17/03/25 download Created with Sketch. 767.42KB
OPT Opthea Announces Phase 2b Wet AMD PublicationPRICE SENSITIVE03/03/25 download Created with Sketch. 262.7KB
OPT Opthea Reports Half Year Results and Business UpdatesPRICE SENSITIVE28/02/25 download Created with Sketch. 319.5KB
OPT Opthea Half Year Financial Report - Appendix 4DPRICE SENSITIVE28/02/25 download Created with Sketch. 1.25MB
OPT Opthea Completes Drug Product PPQ CampaignPRICE SENSITIVE26/02/25 download Created with Sketch. 212.38KB
OPT Opthea Completes COAST Final Week 52 Patient VisitPRICE SENSITIVE18/02/25 download Created with Sketch. 190.33KB
OPT Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/25 download Created with Sketch. 1.49MB
OPT Opthea Investor DayPRICE SENSITIVE29/01/25 download Created with Sketch. 2.98MB
OPT Opthea's Corporate Presentation - Jan 2025PRICE SENSITIVE14/01/25 download Created with Sketch. 1.77MB
OPT Opthea Announces Publication in Diabetic Macular EdemaPRICE SENSITIVE07/01/25 download Created with Sketch. 520.96KB
OPT Opthea's Wet AMD Program to be Featured at FLORetina 2024PRICE SENSITIVE26/11/24 download Created with Sketch. 378.43KB
OPT Opthea Received A$15.9 Million R&D Tax IncentivePRICE SENSITIVE15/11/24 download Created with Sketch. 217.04KB
OPT Chair's Address to ShareholdersPRICE SENSITIVE15/11/24 download Created with Sketch. 234.64KB
OPT Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/10/24 download Created with Sketch. 1.42MB
OPT Opthea Corporate Presentation - Oct 2024PRICE SENSITIVE28/10/24 download Created with Sketch. 1.21MB
OPT Opthea EURetina Symposium 2024PRICE SENSITIVE26/09/24 download Created with Sketch. 1.71MB
OPT Opthea Joins the S&P/ASX 300 IndexPRICE SENSITIVE23/09/24 download Created with Sketch. 269.22KB
OPT Opthea Announces Completion of Drug Substance CampaignPRICE SENSITIVE19/09/24 download Created with Sketch. 460.69KB
OPT Opthea Corporate Presentation - September 2024PRICE SENSITIVE09/09/24 download Created with Sketch. 1.41MB
OPT S&P DJI Announces September 2024 Quarterly RebalancePRICE SENSITIVE06/09/24 download Created with Sketch. 145.4KB
OPT Opthea Reports Full-Year ResultsPRICE SENSITIVE30/08/24 download Created with Sketch. 904.23KB
OPT Opthea Preliminary Final and Annual ReportPRICE SENSITIVE30/08/24 download Created with Sketch. 4.63MB
OPT Updated Quarterly Report and CashflowPRICE SENSITIVE01/08/24 download Created with Sketch. 2.18MB
OPT Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/07/24 download Created with Sketch. 510.6KB
OPT Opthea Welcomes Retina Leaders to its Medical Advisory BoardPRICE SENSITIVE18/07/24 download Created with Sketch. 490.48KB
OPT Security Class Reinstatement to Quotation- OPTOBPRICE SENSITIVE17/07/24 download Created with Sketch. 87.15KB
OPT Opthea Announces Results of Retail Entitlement of A$55.9mPRICE SENSITIVE15/07/24 download Created with Sketch. 302.99KB
OPT Security Class Suspension from Quotation OPTOBPRICE SENSITIVE11/07/24 download Created with Sketch. 420.84KB
OPT Opthea Announces Publication on VEGF- C and DPRICE SENSITIVE10/07/24 download Created with Sketch. 592.91KB
OPT Opthea A$55.0m (US$36.9m) Retail Entitlement Offer OpensPRICE SENSITIVE19/06/24 download Created with Sketch. 407.08KB
OPT Opthea Completes Placement & Institutional Entitlement OfferPRICE SENSITIVE14/06/24 download Created with Sketch. 605.4KB
OPT Opthea - Prospectus 2024PRICE SENSITIVE12/06/24 download Created with Sketch. 1.39MB
OPT Opthea Equity Raise Investor PresentationPRICE SENSITIVE12/06/24 download Created with Sketch. 2.22MB
OPT Opthea Annouces Equity RaisePRICE SENSITIVE12/06/24 download Created with Sketch. 575.16KB
OPT Trading Halt - Accelerated OfferPRICE SENSITIVE12/06/24 download Created with Sketch. 324.77KB
OPT Trading HaltPRICE SENSITIVE07/06/24 download Created with Sketch. 591.78KB
OPT Opthea to Present at Clinical Trials at the Summit MeetingPRICE SENSITIVE03/06/24 download Created with Sketch. 384.44KB
OPT Opthea Completes Enrollment in Phase 3 Clinical ProgramPRICE SENSITIVE28/05/24 download Created with Sketch. 293.41KB
OPT Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE30/04/24 download Created with Sketch. 1.59MB
OPT Opthea Corporate Presentation - April 2024PRICE SENSITIVE05/04/24 download Created with Sketch. 2.03MB
OPT Opthea Key Opinion Leader Even on SoziniberceptPRICE SENSITIVE04/04/24 download Created with Sketch. 2.14MB
OPT Opthea Corporate Presentation - March 2024PRICE SENSITIVE04/03/24 download Created with Sketch. 2.23MB
OPT Opthea Reports Half-Year Results and Business UpdatePRICE SENSITIVE29/02/24 download Created with Sketch. 167.39KB
OPT Half Yearly Report and AccountsPRICE SENSITIVE29/02/24 download Created with Sketch. 1.87MB
OPT Opthea Completes Enrollment in First Trial of SoziniberceptPRICE SENSITIVE15/02/24 download Created with Sketch. 155.38KB
OPT Opthea to Receive US$35M Commitment and Additional US$50MPRICE SENSITIVE27/12/23 download Created with Sketch. 237.52KB
OPT Opthea receives A$8.8 million R&D Tax IncentivePRICE SENSITIVE20/12/23 download Created with Sketch. 159.43KB
OPT 2023 AGM Chairmans AddressPRICE SENSITIVE30/11/23 download Created with Sketch. 159.76KB
OPT Opthea Appoints U.S. Based LeadershipPRICE SENSITIVE27/10/23 download Created with Sketch. 230.69KB
OPT Trading HaltPRICE SENSITIVE25/10/23 download Created with Sketch. 199.79KB
OPT Opthea to Participate at the 2023 Euretina CongressPRICE SENSITIVE03/10/23 download Created with Sketch. 96.62KB
OPT Security Class Reinstatement to Quotation OPTOAPRICE SENSITIVE22/09/23 download Created with Sketch. 85.5KB
OPT Opthea Announces Completion of Retail Entitlement OfferPRICE SENSITIVE21/09/23 download Created with Sketch. 89.22KB
OPT Security Class Suspension from Quotation OPTOAPRICE SENSITIVE15/09/23 download Created with Sketch. 88.15KB
OPT Preliminary Final ReportPRICE SENSITIVE31/08/23 download Created with Sketch. 421.69KB
OPT Opthea Retail Entitlement Offer OpensPRICE SENSITIVE31/08/23 download Created with Sketch. 558.44KB
OPT Opthea completes institutional offer and increases raisePRICE SENSITIVE28/08/23 download Created with Sketch. 154.61KB
OPT ProspectusPRICE SENSITIVE24/08/23 download Created with Sketch. 388.12KB
OPT Opthea Investor PresentationPRICE SENSITIVE24/08/23 download Created with Sketch. 1.85MB
OPT Opthea announces A$80m Capital raisePRICE SENSITIVE24/08/23 download Created with Sketch. 201.33KB
OPT Trading HaltPRICE SENSITIVE24/08/23 download Created with Sketch. 199.53KB
OPT ASRS 2023 - PK and safety of sozinibercept (OPT-302)PRICE SENSITIVE01/08/23 download Created with Sketch. 1.46MB
OPT Opthea Receives A$8.7million R&D Tax IncentivePRICE SENSITIVE07/03/23 download Created with Sketch. 159.63KB
OPT Half Year AccountsPRICE SENSITIVE23/02/23 download Created with Sketch. 1.31MB
OPT Response to ASX QueryPRICE SENSITIVE16/02/23 download Created with Sketch. 314.34KB
OPT Opthea Ph2b Trial Results with OPT-302 published in JournalPRICE SENSITIVE14/02/23 download Created with Sketch. 103.86KB
OPT Opthea Corporate Presentation - San Francisco Jan 2023PRICE SENSITIVE11/01/23 download Created with Sketch. 1.13MB
OPT Chairman's Address to ShareholdersPRICE SENSITIVE16/11/22 download Created with Sketch. 170.52KB
OPT Completion of Share Purchase PlanPRICE SENSITIVE26/09/22 download Created with Sketch. 151.39KB
OPT Opthea reports Fiscal Year 2022 Results and HighlightsPRICE SENSITIVE30/08/22 download Created with Sketch. 151.49KB
OPT Opthea Appendix 4E and Annual Report 2022PRICE SENSITIVE30/08/22 download Created with Sketch. 3.07MB
OPT Opthea Share Purchase PlanPRICE SENSITIVE25/08/22 download Created with Sketch. 898.25KB
OPT Form 6-K with SECPRICE SENSITIVE15/08/22 download Created with Sketch. 141.27KB
OPT Opthea Successfully Closes Well Supported US$90m FinancingPRICE SENSITIVE15/08/22 download Created with Sketch. 127.5KB
OPT Opthea secures up to US$170m in non-dilutive financingPRICE SENSITIVE15/08/22 download Created with Sketch. 137.42KB
OPT Trading HaltPRICE SENSITIVE11/08/22 download Created with Sketch. 273.91KB
OPT Opthea Data for OPT-302 for PCV presented at ARVO 2022PRICE SENSITIVE06/05/22 download Created with Sketch. 164.12KB
OPT Opthea Presenting Clinical Data at ARVO 2022 Annual MeetingPRICE SENSITIVE02/05/22 download Created with Sketch. 104.6KB
OPT S&P DJI Announces March 2022 Quarterly RebalancePRICE SENSITIVE04/03/22 download Created with Sketch. 175.5KB
OPT Opthea Half Year Report and AccountsPRICE SENSITIVE28/02/22 download Created with Sketch. 1.16MB
OPT Angiogenesis 2022 -Prof Cheung presentation of PCV dataPRICE SENSITIVE14/02/22 download Created with Sketch. 680.37KB
OPT Opthea data for OPT-302 in patients with PVC as presentedPRICE SENSITIVE14/02/22 download Created with Sketch. 182.15KB
OPT Opthea announces establishment of ATM Equity ProgramPRICE SENSITIVE02/02/22 download Created with Sketch. 150.66KB
OPT Form F-3 Registration StatementPRICE SENSITIVE02/02/22 download Created with Sketch. 876.99KB
OPT Opthea Receives A$6.6m R&D Tax IncentivePRICE SENSITIVE25/01/22 download Created with Sketch. 182.04KB
OPT Opthea Granted Chinese Patent Covering OPT-302PRICE SENSITIVE27/10/21 download Created with Sketch. 87.94KB
OPT Opthea opens patient enrollment in the Asia-Pacifi RegionPRICE SENSITIVE20/10/21 download Created with Sketch. 132.58KB
OPT S&P DJI Announces September 2025 Quarterly Rebalance
05/09/25PRICE SENSITIVE download Created with Sketch. 121.47KB
OPT Preliminary Final Report
29/08/25PRICE SENSITIVE download Created with Sketch. 325.85KB
OPT Corporate Update Investor Call
20/08/25PRICE SENSITIVE download Created with Sketch. 296.94KB
OPT Opthea Provides Corporate Update
19/08/25PRICE SENSITIVE download Created with Sketch. 196.61KB
OPT Quarterly Activities/Appendix 4C Cash Flow Report
30/07/25PRICE SENSITIVE download Created with Sketch. 1.48MB
OPT Long Term Suspended Entities
16/07/25PRICE SENSITIVE download Created with Sketch. 262.84KB
OPT Opthea Provides Corporate Update
02/06/25PRICE SENSITIVE download Created with Sketch. 487.15KB
OPT Quarterly Activities/Appendix 4C Cash Flow Report
30/04/25PRICE SENSITIVE download Created with Sketch. 1.48MB
OPT Opthea Provides Corporate Update
10/04/25PRICE SENSITIVE download Created with Sketch. 485.05KB
OPT Continuation of Suspension from Quotation
31/03/25PRICE SENSITIVE download Created with Sketch. 109.5KB
OPT Opthea Announces Decision to Discontinue Wet AMD Trials
31/03/25PRICE SENSITIVE download Created with Sketch. 491.5KB
OPT Opthea Announces COAST Phase 3 Trial Topline Results
24/03/25PRICE SENSITIVE download Created with Sketch. 520.92KB
OPT Voluntary suspension
19/03/25PRICE SENSITIVE download Created with Sketch. 1.07MB
OPT Trading Halt
17/03/25PRICE SENSITIVE download Created with Sketch. 767.42KB
OPT Opthea Announces Phase 2b Wet AMD Publication
03/03/25PRICE SENSITIVE download Created with Sketch. 262.7KB
OPT Opthea Reports Half Year Results and Business Updates
28/02/25PRICE SENSITIVE download Created with Sketch. 319.5KB
OPT Opthea Half Year Financial Report - Appendix 4D
28/02/25PRICE SENSITIVE download Created with Sketch. 1.25MB
OPT Opthea Completes Drug Product PPQ Campaign
26/02/25PRICE SENSITIVE download Created with Sketch. 212.38KB
OPT Opthea Completes COAST Final Week 52 Patient Visit
18/02/25PRICE SENSITIVE download Created with Sketch. 190.33KB
OPT Quarterly Activities/Appendix 4C Cash Flow Report
31/01/25PRICE SENSITIVE download Created with Sketch. 1.49MB
OPT Opthea Investor Day
29/01/25PRICE SENSITIVE download Created with Sketch. 2.98MB
OPT Opthea's Corporate Presentation - Jan 2025
14/01/25PRICE SENSITIVE download Created with Sketch. 1.77MB
OPT Opthea Announces Publication in Diabetic Macular Edema
07/01/25PRICE SENSITIVE download Created with Sketch. 520.96KB
OPT Opthea's Wet AMD Program to be Featured at FLORetina 2024
26/11/24PRICE SENSITIVE download Created with Sketch. 378.43KB
OPT Opthea Received A$15.9 Million R&D Tax Incentive
15/11/24PRICE SENSITIVE download Created with Sketch. 217.04KB
OPT Chair's Address to Shareholders
15/11/24PRICE SENSITIVE download Created with Sketch. 234.64KB
OPT Quarterly Activities/Appendix 4C Cash Flow Report
31/10/24PRICE SENSITIVE download Created with Sketch. 1.42MB
OPT Opthea Corporate Presentation - Oct 2024
28/10/24PRICE SENSITIVE download Created with Sketch. 1.21MB
OPT Opthea EURetina Symposium 2024
26/09/24PRICE SENSITIVE download Created with Sketch. 1.71MB
OPT Opthea Joins the S&P/ASX 300 Index
23/09/24PRICE SENSITIVE download Created with Sketch. 269.22KB
OPT Opthea Announces Completion of Drug Substance Campaign
19/09/24PRICE SENSITIVE download Created with Sketch. 460.69KB
OPT Opthea Corporate Presentation - September 2024
09/09/24PRICE SENSITIVE download Created with Sketch. 1.41MB
OPT S&P DJI Announces September 2024 Quarterly Rebalance
06/09/24PRICE SENSITIVE download Created with Sketch. 145.4KB
OPT Opthea Reports Full-Year Results
30/08/24PRICE SENSITIVE download Created with Sketch. 904.23KB
OPT Opthea Preliminary Final and Annual Report
30/08/24PRICE SENSITIVE download Created with Sketch. 4.63MB
OPT Updated Quarterly Report and Cashflow
01/08/24PRICE SENSITIVE download Created with Sketch. 2.18MB
OPT Quarterly Activities/Appendix 4C Cash Flow Report
31/07/24PRICE SENSITIVE download Created with Sketch. 510.6KB
OPT Opthea Welcomes Retina Leaders to its Medical Advisory Board
18/07/24PRICE SENSITIVE download Created with Sketch. 490.48KB
OPT Security Class Reinstatement to Quotation- OPTOB
17/07/24PRICE SENSITIVE download Created with Sketch. 87.15KB
OPT Opthea Announces Results of Retail Entitlement of A$55.9m
15/07/24PRICE SENSITIVE download Created with Sketch. 302.99KB
OPT Security Class Suspension from Quotation OPTOB
11/07/24PRICE SENSITIVE download Created with Sketch. 420.84KB
OPT Opthea Announces Publication on VEGF- C and D
10/07/24PRICE SENSITIVE download Created with Sketch. 592.91KB
OPT Opthea A$55.0m (US$36.9m) Retail Entitlement Offer Opens
19/06/24PRICE SENSITIVE download Created with Sketch. 407.08KB
OPT Opthea Completes Placement & Institutional Entitlement Offer
14/06/24PRICE SENSITIVE download Created with Sketch. 605.4KB
OPT Opthea - Prospectus 2024
12/06/24PRICE SENSITIVE download Created with Sketch. 1.39MB
OPT Opthea Equity Raise Investor Presentation
12/06/24PRICE SENSITIVE download Created with Sketch. 2.22MB
OPT Opthea Annouces Equity Raise
12/06/24PRICE SENSITIVE download Created with Sketch. 575.16KB
OPT Trading Halt - Accelerated Offer
12/06/24PRICE SENSITIVE download Created with Sketch. 324.77KB
OPT Trading Halt
07/06/24PRICE SENSITIVE download Created with Sketch. 591.78KB
OPT Opthea to Present at Clinical Trials at the Summit Meeting
03/06/24PRICE SENSITIVE download Created with Sketch. 384.44KB
OPT Opthea Completes Enrollment in Phase 3 Clinical Program
28/05/24PRICE SENSITIVE download Created with Sketch. 293.41KB
OPT Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24PRICE SENSITIVE download Created with Sketch. 1.59MB
OPT Opthea Corporate Presentation - April 2024
05/04/24PRICE SENSITIVE download Created with Sketch. 2.03MB
OPT Opthea Key Opinion Leader Even on Sozinibercept
04/04/24PRICE SENSITIVE download Created with Sketch. 2.14MB
OPT Opthea Corporate Presentation - March 2024
04/03/24PRICE SENSITIVE download Created with Sketch. 2.23MB
OPT Opthea Reports Half-Year Results and Business Update
29/02/24PRICE SENSITIVE download Created with Sketch. 167.39KB
OPT Half Yearly Report and Accounts
29/02/24PRICE SENSITIVE download Created with Sketch. 1.87MB
OPT Opthea Completes Enrollment in First Trial of Sozinibercept
15/02/24PRICE SENSITIVE download Created with Sketch. 155.38KB
OPT Opthea to Receive US$35M Commitment and Additional US$50M
27/12/23PRICE SENSITIVE download Created with Sketch. 237.52KB
OPT Opthea receives A$8.8 million R&D Tax Incentive
20/12/23PRICE SENSITIVE download Created with Sketch. 159.43KB
OPT 2023 AGM Chairmans Address
30/11/23PRICE SENSITIVE download Created with Sketch. 159.76KB
OPT Opthea Appoints U.S. Based Leadership
27/10/23PRICE SENSITIVE download Created with Sketch. 230.69KB
OPT Trading Halt
25/10/23PRICE SENSITIVE download Created with Sketch. 199.79KB
OPT Opthea to Participate at the 2023 Euretina Congress
03/10/23PRICE SENSITIVE download Created with Sketch. 96.62KB
OPT Security Class Reinstatement to Quotation OPTOA
22/09/23PRICE SENSITIVE download Created with Sketch. 85.5KB
OPT Opthea Announces Completion of Retail Entitlement Offer
21/09/23PRICE SENSITIVE download Created with Sketch. 89.22KB
OPT Security Class Suspension from Quotation OPTOA
15/09/23PRICE SENSITIVE download Created with Sketch. 88.15KB
OPT Preliminary Final Report
31/08/23PRICE SENSITIVE download Created with Sketch. 421.69KB
OPT Opthea Retail Entitlement Offer Opens
31/08/23PRICE SENSITIVE download Created with Sketch. 558.44KB
OPT Opthea completes institutional offer and increases raise
28/08/23PRICE SENSITIVE download Created with Sketch. 154.61KB
OPT Prospectus
24/08/23PRICE SENSITIVE download Created with Sketch. 388.12KB
OPT Opthea Investor Presentation
24/08/23PRICE SENSITIVE download Created with Sketch. 1.85MB
OPT Opthea announces A$80m Capital raise
24/08/23PRICE SENSITIVE download Created with Sketch. 201.33KB
OPT Trading Halt
24/08/23PRICE SENSITIVE download Created with Sketch. 199.53KB
OPT ASRS 2023 - PK and safety of sozinibercept (OPT-302)
01/08/23PRICE SENSITIVE download Created with Sketch. 1.46MB
OPT Opthea Receives A$8.7million R&D Tax Incentive
07/03/23PRICE SENSITIVE download Created with Sketch. 159.63KB
OPT Half Year Accounts
23/02/23PRICE SENSITIVE download Created with Sketch. 1.31MB
OPT Response to ASX Query
16/02/23PRICE SENSITIVE download Created with Sketch. 314.34KB
OPT Opthea Ph2b Trial Results with OPT-302 published in Journal
14/02/23PRICE SENSITIVE download Created with Sketch. 103.86KB
OPT Opthea Corporate Presentation - San Francisco Jan 2023
11/01/23PRICE SENSITIVE download Created with Sketch. 1.13MB
OPT Chairman's Address to Shareholders
16/11/22PRICE SENSITIVE download Created with Sketch. 170.52KB
OPT Completion of Share Purchase Plan
26/09/22PRICE SENSITIVE download Created with Sketch. 151.39KB
OPT Opthea reports Fiscal Year 2022 Results and Highlights
30/08/22PRICE SENSITIVE download Created with Sketch. 151.49KB
OPT Opthea Appendix 4E and Annual Report 2022
30/08/22PRICE SENSITIVE download Created with Sketch. 3.07MB
OPT Opthea Share Purchase Plan
25/08/22PRICE SENSITIVE download Created with Sketch. 898.25KB
OPT Form 6-K with SEC
15/08/22PRICE SENSITIVE download Created with Sketch. 141.27KB
OPT Opthea Successfully Closes Well Supported US$90m Financing
15/08/22PRICE SENSITIVE download Created with Sketch. 127.5KB
OPT Opthea secures up to US$170m in non-dilutive financing
15/08/22PRICE SENSITIVE download Created with Sketch. 137.42KB
OPT Trading Halt
11/08/22PRICE SENSITIVE download Created with Sketch. 273.91KB
OPT Opthea Data for OPT-302 for PCV presented at ARVO 2022
06/05/22PRICE SENSITIVE download Created with Sketch. 164.12KB
OPT Opthea Presenting Clinical Data at ARVO 2022 Annual Meeting
02/05/22PRICE SENSITIVE download Created with Sketch. 104.6KB
OPT S&P DJI Announces March 2022 Quarterly Rebalance
04/03/22PRICE SENSITIVE download Created with Sketch. 175.5KB
OPT Opthea Half Year Report and Accounts
28/02/22PRICE SENSITIVE download Created with Sketch. 1.16MB
OPT Angiogenesis 2022 -Prof Cheung presentation of PCV data
14/02/22PRICE SENSITIVE download Created with Sketch. 680.37KB
OPT Opthea data for OPT-302 in patients with PVC as presented
14/02/22PRICE SENSITIVE download Created with Sketch. 182.15KB
OPT Opthea announces establishment of ATM Equity Program
02/02/22PRICE SENSITIVE download Created with Sketch. 150.66KB
OPT Form F-3 Registration Statement
02/02/22PRICE SENSITIVE download Created with Sketch. 876.99KB
OPT Opthea Receives A$6.6m R&D Tax Incentive
25/01/22PRICE SENSITIVE download Created with Sketch. 182.04KB
OPT Opthea Granted Chinese Patent Covering OPT-302
27/10/21PRICE SENSITIVE download Created with Sketch. 87.94KB
OPT Opthea opens patient enrollment in the Asia-Pacifi Region
20/10/21PRICE SENSITIVE download Created with Sketch. 132.58KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
60.0¢
Change
0.000(0.00%)
Mkt cap ! $820.7M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.